智通财经APP获悉,Esperion Therapeutics(ESPR.US)披露日本第一三共欧洲子公司Daiichi Sankyo Europe(DSE)不同意其拖欠该公司的两种含bempedoic acid的降胆固醇药物的里程碑付款。截至发稿,Esperion盘后跌近54%,报1.72美元 Espierion... 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-029114 Size: 18 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-029116 Size: 19 KB 网页链接
$Esperion(ESPR)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001273087-24-000077 Act: 34 Size: 81 KB 网页链接
$Esperion(ESPR)$ 8-K Current report, items 5.02, 5.07, and 9.01 Accession Number: 0001628280-24-025418 Act: 34 Size: 380 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-025210 Size: 19 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-025213 Size: 19 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-025217 Size: 20 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-025219 Size: 20 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-025221 Size: 22 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-025223 Size: 19 KB 网页链接